Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
暂无分享,去创建一个
G. Antoch | P. Heusch | C. Buchbender | T. Gauler | L. Umutlu | M. Metzenmacher | B. Schaarschmidt | J. Grueneisen | B. Gomez | Verena Ruhlmann | C. Roesel | Martin Metzenmacher